Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Asia-Pacific IVF Services Market by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor egg IVF cycle) and End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Analysis and Industry Forecast, 2019–2028

A00710
Pages: 372
May 2020 | 17152 Views
 
Author(s) : Snehal Manjrekar,Trupti Wadekar & Onkar Sumant
Tables: 153
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Asia-pacific Ivf Services Market

Request Now !

The Asia-Pacific IVF Services Market size was valued at $8,100.04 million in 2018, and is expected to reach $24,216.42 million by 2028, registering a CAGR of 11.6% from 2019 to 2028. In vitro fertilization (IVF) process involves fertilization of egg cells by sperm outside the woman’s bodyand then implanting it in the uterus. It is a type of assisted reproductive technology (ART) based treatment which is used to treat fertility or genetic problems to assists with the conception of child. It is the process of fertilization, which includes eggs extraction, sperm cell sample retrieval, and then manually combining an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the uterus for further gestation.

Asia-Pacific-IVF-Services-Market-2019-2027

Get more information on this report : Request Sample Pages

The Asia Pacific IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of late pregnancies, surge in IVF success rate, and rise in disposable income in the region. IVF is one of the widely used treatments, which assist couples with infertility problems, single mothers, and the LGBT community to procreate. Moreover, rise in fertility tourismprovides steady prospects for the growth of the IVF services market in Asia-Pacific. In addition,increase in number of fertility clinics and growth opportunities in emerging markets are expected to boost the Asia-Pacific IVF market in the future.

Asia-Pacific presents productive opportunities for the players operating in the IVF services market, owing to its high population base, growth in knowledge about IVF treatment, low cost of IVF treatments, rise in number of infertile population, and surge in disposable income. In older women (more than 40 years age group), eggs produced by the reproductive system are not fully formed for the process of fertilization. This results in the risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in the production of healthy eggs and increasechances of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to drive the growth of the IVF services market. 

However, complications associated with IVF treatment such as multiple pregnancies and birth defects; and lower awareness regarding IVF in some under developed regions hinder the growth of the market.

Asia-pacific Ivf Services Market Segmentation

The Asia-Pacific IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, the Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.

Asia-Pacific IVF Services Market
By Cycle Type

Your browser does not support the canvas element.

Fresh Cycle Segment is expected to dominate the market during forecast period.

Get more information on this report : Request Sample Pages

Cycle Type Segment Review

The cycle type segment is divided into fresh (non-donor) IVF cycles, thawed (non-donor) IVF cycles, and donor egg IVF cycles. The fresh cycle (non-donor) segment was the major revenue contributor in 2018. The fresh embryo IVF cycle begins with the ovarian stimulation, which is followed by retrieval of all eggs from the patient. These eggs are reinserted within the woman’s body to create an embryo. Any remaining good quality embryos are frozen, which can be used in the future frozen IVF cycles.The segment is expected to dominate the market throughoutthe forecast period.

Asia-Pacific IVF Services Market
By End user

Your browser does not support the canvas element.

Fertility Clinics segment is anticipated to be the highest revenue contributor in 2018

Get more information on this report : Request Sample Pages

End User Segment Review

By end user, fertility clinics and clinical research institute segments play a crucial role in  providing IVF treatments to couples seeking assistance for infertility.Availability of a wide range of fertility treatments under one roof majorly drive the growth of the Asia-Pacific IVF services market by fertility clinics segment. The fertility clinics segment was the largest revenuegenerating segmentfrom in 2018.

Asia-Pacific IVF Services Market
By Country

2028
China 
India
Japan
Australia
New Zealand
South Korea
Thailand
Singapore
Malaysia
Indonesia
Philippines
Vietnam
Myanmar
Rest Of Asia-pacific

China is the major revenue generator in the Asia-Pacific IVF services market

Get more information on this report : Request Sample Pages

The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.

Key Benefits For Stakeholders

  • The Asia-Pacific IVF services market share and analysis is based on a comprehensive analysis of key developments in IVF services.

  • The development strategies adopted by key market players are enlisted to understand the competitive scenario of the Asia-Pacific market.

  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.

  • The Asia-Pacific IVF services market trends are studied from 2018 to 2028.

  • Information about key drivers, restrains, and opportunities and their impact analysis on the IVF services market size is provided.

  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in theIVF services industry.

  • The quantitative analysis of the Asia-Pacific IVF services market from 2019 to 2028 is provided to determine the market potential.

Key Market Segments

By Cycle Type

  • Fresh IVF Cycles (Non-Donor)
  • Thawed IVF Cycles (Non-Donor)
  • Donor Egg IVF Cycles

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical centers
  • Clinical research institutes

By Country

  • Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • New Zealand
  • South Korea
  • Thailand
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
  • Vietnam
  • Myanmar
  • Rest of Asia-Pacific
 

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Asia-Pacific IVF Services Market, By End User

3.2.1. Market size and forecast
3.2.2. Market volume and forecast
3.2.3. Fertility clinics

3.2.3.1. Market size and forecast

3.2.4. Hospitals

3.2.4.1. Market size and forecast

3.2.5. Surgical centers

3.2.5.1. Market size and forecast

3.2.6. Clinical research institutes

3.2.6.1. Market size and forecast

3.3. Asia-Pacific IVF Services Market, by Cycle Type

3.3.1. Market size and forecast
3.3.2. Market volume and forecast
3.3.3. Fresh IVF cycles (non-donor)

3.3.3.1. Market size and forecast

3.3.4. Thawed IVF cycles (non-donor)

3.3.4.1. Market size and forecast

3.3.5. Donor egg IVF cycles

3.3.5.1. Market size and forecast

3.4. Asia-Pacific IVF services market, by country

3.4.1. Limitations of foreign investment

3.4.1.1. India
3.4.1.2. China
3.4.1.3. Japan
3.4.1.4. Australia
3.4.1.5. New Zealand
3.4.1.6. South Korea
3.4.1.7. Thailand
3.4.1.8. Singapore
3.4.1.9. Malaysia
3.4.1.10. Indonesia
3.4.1.11. Philippines
3.4.1.12. Vietnam
3.4.1.13. Myanmar

3.4.2. Market size and forecast
3.4.3. Market volume and forecast

3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Delayed pregnancies in women
3.5.1.2. Increase in global infertility rates
3.5.1.3. Increase in gamete donations
3.5.1.4. Increase in disposable income
3.5.1.5. Increase in IVF success rates

3.5.2. Restraints

3.5.2.1. Complications associated with IVF treatment
3.5.2.2. Low awareness level

3.5.3. Opportunities

3.5.3.1. Fertility tourism
3.5.3.2. Growth opportunities in the Asia-Pacific region
3.5.3.3. Increase in number of fertility clinics

3.5.4. Impact analyses

CHAPTER 4: INDIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

4.1. Overview

4.1.1. Market size and forecast

4.2. Fertility Center in India
4.3. India IVF Services Market, By End User

4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.3.3. Fertility clinics
4.3.4. Hospitals
4.3.5. Surgical Centers
4.3.6. Clinical research institutes

4.4. India IVF Services Market, By Cycle Type

4.4.1. Market size and forecast
4.4.2. Market volume and forecast
4.4.3. Fresh IVF cycles (non-donor)
4.4.4. Thawed IVF cycles (non-donor)
4.4.5. Donor egg IVF cycles

4.5. Market Dynamics

4.5.1. Driving factors
4.5.2. Restraining factors

4.6. Regulatory Issues, Legislations and Authorities
4.7. Insurance Reimbursement Scenario
4.8. Company Profiles

4.8.1. Bourn Hall Fertility Center

4.8.1.1. Company overview

4.8.2. Southend Fertility and IVF

4.8.2.1. Company overview

4.8.3. Morpheus Life Sciences Pvt. Ltd.

4.8.3.1. Company overview

4.8.4. Bloom Fertility Center

4.8.4.1. Company overview

4.8.5. Bloom Fertility and Healthcare

4.8.5.1. Company overview

4.8.6. Manipal Fertility

4.8.6.1. Company overview

4.8.7. Cloudnine Fertility

4.8.7.1. Company overview

4.8.8. Chennai Fertility Center

4.8.8.1. Company overview

CHAPTER 5: CHINA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

5.1. Overview

5.1.1. Market size and forecast

5.2. China IVF Services Market, By End User

5.2.1. Market size and forecast
5.2.2. Market volume and forecast
5.2.3. Fertility clinics
5.2.4. Hospitals
5.2.5. Surgical Centers
5.2.6. Clinical research institutes

5.3. China IVF Services Market, By Cycle Type

5.3.1. Market size and forecast
5.3.2. Market volume and forecast
5.3.3. Fresh IVF cycles (non-donor)
5.3.4. Thawed IVF cycles (non-donor)
5.3.5. Donor egg IVF cycles

5.4. Market Dynamics

5.4.1. Driving factors
5.4.2. Restraining Factors

5.5. Regulatory Issues, Legislations and Authorities
5.6. Insurance Reimbursement Scenario
5.7. Company Profiles

5.7.1. Shanghai Ji Ai Genetics & IVF Institute

5.7.1.1. Company overview

5.7.2. Shanghai United Family Hospital

5.7.2.1. Company overview

CHAPTER 6: JAPAN IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

6.1. Overview

6.1.1. Market size and forecast

6.2. Japan IVF services market, by end user

6.2.1. Market size and forecast
6.2.2. Market volume and forecast
6.2.3. Fertility clinics
6.2.4. Hospitals
6.2.5. Surgical Centers
6.2.6. Clinical research institutes

6.3. Japan IVF Services Market, By Cycle Type

6.3.1. Market size and forecast
6.3.2. Market volume and forecast
6.3.3. Fresh IVF cycles (non-donor)
6.3.4. Thawed IVF cycles (non-donor)
6.3.5. Donor egg IVF cycles

6.4. Market Dynamics

6.4.1. Driving factors
6.4.2. Restraining Factors

6.5. Regulatory Issues, Legislations and Authorities
6.6. Insurance Reimbursement Scenario
6.7. Company Profiles

6.7.1. IVF NAMBA Clinic

6.7.1.1. Company overview

6.7.2. Sanno Hospital

6.7.2.1. Company overview

6.7.3. Oak Medical Group/Oak Clinic

6.7.3.1. Company overview

CHAPTER 7: AUSTRALIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

7.1. Overview

7.1.1. Market size and forecast

7.2. Fertility Center in Australia
7.3. Australia IVF Services Market, By End User

7.3.1. Market size and forecast
7.3.2. Market volume and forecast
7.3.3. Fertility clinics
7.3.4. Hospitals
7.3.5. Surgical Centers
7.3.6. Clinical research institutes

7.4. Australia IVF Services Market, By Cycle Type

7.4.1. Market size and forecast
7.4.2. Market volume and forecast
7.4.3. Fresh IVF cycles (non-donor)
7.4.4. Thawed IVF cycles (non-donor)
7.4.5. Donor egg IVF cycles

7.5. Market Dynamics

7.5.1. Driving factors
7.5.2. Restraining Factors

7.6. Regulatory Issues, Legislations and Authorities
7.7. Insurance Reimbursement Scenario
7.8. Company Profiles

7.8.1. Virtus Health

7.8.1.1. Company overview

7.8.2. Monash IVF Wesley Hospital Auchenflower

7.8.2.1. Company overview

7.8.3. Fertility First

7.8.3.1. Company overview

7.8.4. Flinders Reproductive Medicine Pty Ltd

7.8.4.1. Company overview

CHAPTER 8: NEW ZEALAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

8.1. Overview

8.1.1. Market size and forecast

8.2. New Zealand IVF Services Market, By End User

8.2.1. Market size and forecast
8.2.2. Market volume and forecast
8.2.3. Fertility clinics
8.2.4. Hospitals
8.2.5. Surgical Centers
8.2.6. Clinical research institutes

8.3. New Zealand IVF Services Market, By Cycle Type

8.3.1. Market size and forecast
8.3.2. Market volume and forecast
8.3.3. Fresh IVF cycles (non-donor)
8.3.4. Thawed IVF cycles (non-donor)
8.3.5. Donor egg IVF cycles

8.4. Market Dynamics

8.4.1. Driving factors
8.4.2. Restraining Factors

8.5. Regulatory Issues, Legislations and Authorities
8.6. Insurance Reimbursement Scenario
8.7. Company Profiles

8.7.1. Fertility Associates

8.7.1.1. Company overview

8.7.2. Genea Oxford Fertility Limited

8.7.2.1. Company overview

8.7.3. Repromed

8.7.3.1. Company overview

CHAPTER 9: SOUTH KOREA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

9.1. Overview

9.1.1. Market size and forecast

9.2. Fertility Center in South Korea
9.3. South Korea IVF Services Market, By End User

9.3.1. Market size and forecast
9.3.2. Market volume and forecast
9.3.3. Fertility clinics
9.3.4. Hospitals
9.3.5. Surgical Centers
9.3.6. Clinical research institutes

9.4. South Korea IVF Services Market, By Cycle Type

9.4.1. Market size and forecast
9.4.2. Market volume and forecast
9.4.3. Fresh IVF cycles (non-donor)
9.4.4. Thawed IVF cycles (non-donor)
9.4.5. Donor egg IVF cycles

9.5. Market Dynamics

9.5.1. Driving factors
9.5.2. Restraining Factors

9.6. Regulatory Issues, Legislations and Authorities
9.7. Insurance Reimbursement Scenario
9.8. Company Profiles

9.8.1. CHA Fertility Center

9.8.1.1. Company overview

9.8.2. Maria Fertility Hospital

9.8.2.1. Company overview

CHAPTER 10: THAILAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

10.1. Overview

10.1.1. Market size and forecast

10.2. Thailand IVF Services Market, By End User

10.2.1. Market size and forecast
10.2.2. Market volume and forecast
10.2.3. Fertility clinics
10.2.4. Hospitals
10.2.5. Surgical Centers
10.2.6. Clinical research institutes

10.3. Thailand IVF Services Market, By Cycle Type

10.3.1. Market size and forecast
10.3.2. Market volume and forecast
10.3.3. Fresh IVF cycles (non-donor)
10.3.4. Thawed IVF cycles (non-donor)
10.3.5. Donor egg IVF cycles

10.4. Market Dynamics

10.4.1. Driving factors
10.4.2. Restraining Factors

10.5. Regulatory Issues, Legislations and Authorities
10.6. Insurance Reimbursement Scenario
10.7. Company Profiles

10.7.1. SAFE Fertility Center

10.7.1.1. Company overview

10.7.2. Bangkok IVF Center (Bangkok Hospital)

10.7.2.1. Company overview

10.7.3. Bangkok IVF center

10.7.3.1. Company overview

CHAPTER 11: SINGAPORE IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

11.1. Overview

11.1.1. Market size and forecast

11.2. Singapore IVF Services Market, By End User

11.2.1. Market size and forecast
11.2.2. Market volume and forecast
11.2.3. Fertility clinics
11.2.4. Hospitals
11.2.5. Surgical Centers
11.2.6. Clinical research institutes

11.3. Singapore IVF Services Market, By Cycle Type

11.3.1. Market size and forecast
11.3.2. Market volume and forecast
11.3.3. Fresh IVF cycles (non-donor)
11.3.4. Thawed IVF cycles (non-donor)
11.3.5. Donor egg IVF cycles

11.4. Market Dynamics

11.4.1. Driving factors
11.4.2. Restraining factors

11.5. Regulatory Issues, Legislations and Authorities
11.6. Insurance Reimbursement Scenario
11.7. Company Profiles

11.7.1. National University Hospital

11.7.1.1. Company overview

11.7.2. IHH Healthcare Berhad

11.7.2.1. Company overview

11.7.3. Thomson Medical Pte. Ltd.

11.7.3.1. Company overview

11.7.4. Raffles Medical Group

11.7.4.1. Company overview

CHAPTER 12: MALAYSIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

12.1. Overview

12.1.1. Market size and forecast

12.2. Malaysia IVF Services Market, By End User

12.2.1. Market size and forecast
12.2.2. Market volume and forecast
12.2.3. Fertility clinics
12.2.4. Hospitals
12.2.5. Surgical Centers
12.2.6. Clinical research institutes

12.3. Malaysia IVF Services Market, By Cycle Type

12.3.1. Market size and forecast
12.3.2. Market volume and forecast
12.3.3. Fresh IVF cycles (non-donor)
12.3.4. Thawed IVF cycles (non-donor)
12.3.5. Donor egg IVF cycles

12.4. Market Dynamics

12.4.1. Driving factors
12.4.2. Restraining factors

12.5. Regulatory Issues, Legislations and Authorities
12.6. Insurance Reimbursement Scenario
12.7. Company Profiles

12.7.1. Damai Service Hospital

12.7.1.1. Company overview

12.7.2. TMC Fertility Centre

12.7.2.1. Company overview

12.7.3. KL Fertility & Gynecology Centre

12.7.3.1. Company overview

CHAPTER 13: INDONESIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

13.1. Overview

13.1.1. Market size and forecast

13.2. Indonesia IVF Services Market, By End User

13.2.1. Market size and forecast
13.2.2. Market volume and forecast
13.2.3. Fertility clinics
13.2.4. Hospitals
13.2.5. Surgical Centers
13.2.6. Clinical research institutes

13.3. Indonesia IVF Services Market, By Cycle Type

13.3.1. Market size and forecast
13.3.2. Market volume and forecast
13.3.3. Fresh IVF cycles (non-donor)
13.3.4. Thawed IVF cycles (non-donor)
13.3.5. Donor egg IVF cycles

13.4. Market Dynamics

13.4.1. Driving factors
13.4.2. Restraining factors

13.5. Regulatory Issues, Legislations and Authorities
13.6. Insurance Reimbursement Scenario
13.7. Company Profiles

13.7.1. Morula IVF

13.7.1.1. Company overview

13.7.2. Lotus Fertility Clinic

13.7.2.1. Company overview

13.7.3. RSUP Dr. Hasan Sadikin Bandung

13.7.3.1. Company overview

CHAPTER 14: PHILIPPINES IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

14.1. Overview

14.1.1. Market size and forecast

14.2. Philippines IVF Services Market, By End User

14.2.1. Market size and forecast
14.2.2. Market volume and forecast
14.2.3. Fertility clinics
14.2.4. Hospitals
14.2.5. Surgical Centers
14.2.6. Clinical research institutes

14.3. Philippines IVF Services Market, By Cycle Type

14.3.1. Market size and forecast
14.3.2. Market volume and forecast
14.3.3. Fresh IVF cycles (non-donor)
14.3.4. Thawed IVF cycles (non-donor)
14.3.5. Donor egg IVF cycles

14.4. Market Dynamics

14.4.1. Driving factors
14.4.2. Restraining factors

14.5. Regulatory Issues, Legislations and Authorities
14.6. Insurance Reimbursement Scenario
14.7. Company Profiles

14.7.1. Victory A.R.T. Laboratory Phils., Inc.

14.7.1.1. Company overview

14.7.2. Center for Advanced Reproductive Medicine and Infertility

14.7.2.1. Company overview

CHAPTER 15: VIETNAM IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)

15.1. Overview

15.1.1. Market size and forecast

15.2. Vietnam IVF Services Market, By End User

15.2.1. Market size and forecast
15.2.2. Market volume and forecast
15.2.3. Fertility clinics
15.2.4. Hospitals
15.2.5. Surgical Centers
15.2.6. Clinical research institutes

15.3. Vietnam IVF Services Market, By Cycle Type

15.3.1. Market size and forecast
15.3.2. Market volume and forecast
15.3.3. Fresh IVF cycles (non-donor)
15.3.4. Thawed IVF cycles (non-donor)
15.3.5. Donor egg IVF cycles

15.4. Market Dynamics

15.4.1. Driving factors
15.4.2. Restraining factors

15.5. Regulatory Issues, Legislations and Authorities
15.6. Insurance Reimbursement Scenario
15.7. Company Profiles

15.7.1. IVF Van Hanh

15.7.1.1. Company overview

15.7.2. Tu Du Hospital

15.7.2.1. Company overview

CHAPTER 16: MYANMAR IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)

16.1. Overview
16.2. Market size and forecast
16.3. Myanmar IVF Services Market, By End User

16.3.1. Market size and forecast
16.3.2. Market volume and forecast
16.3.3. Fertility clinics
16.3.4. Hospitals
16.3.5. Surgical centers
16.3.6. Clinical research institutes

16.4. Myanmar IVF Services Market, By Cycle Type

16.4.1. Market size and forecast
16.4.2. Market volume and forecast
16.4.3. Fresh IVF cycles (non-donor)
16.4.4. Thawed IVF cycles (non-donor)

16.5. Market Dynamics

16.5.1. Driving factors
16.5.2. Restraining factors

16.6. Regulatory issues, legislations, and authorities
16.7. Insurance Reimbursement Scenario
16.8. Company Profiles

16.8.1. Bahosi Fertility Centre

16.8.1.1. Company overview

16.8.2. Bumrungrad International Hospital

16.8.2.1. Company overview

16.8.3. Superior A.R.T Myanmar

16.8.3.1. Company overview

CHAPTER 17: REST OF ASIA-PACIFIC IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)

17.1. Overview

17.1.1. Market size and forecast

17.2. Rest of Asia-Pacific IVF Services Market, By End User

17.2.1. Market size and forecast
17.2.2. Market volume and forecast
17.2.3. Fertility clinics
17.2.4. Hospitals
17.2.5. Surgical centers
17.2.6. Clinical research institutes

17.3. Rest of Asia-Pacific IVF Services Market, By Cycle Type

17.3.1. Market size and forecast
17.3.2. Market volume and forecast
17.3.3. Fresh IVF cycles (non-donor)
17.3.4. Thawed IVF cycles (non-donor)
17.3.5. Donor egg IVF cycles

17.4. Market Dynamics

17.4.1. Driving factors
17.4.2. Restraining factors

17.5. Regulatory issues, legislations, and authorities
17.6. Insurance Reimbursement Scenario
17.7. Company Profiles

LIST OF TABLES

TABLE 01. ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY END USER, 2017-2028 ($MILLION)
TABLE 02. ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY END USER, 2017-2028 (THOUSAND)
TABLE 03. ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2028 ($MILLION)
TABLE 04. ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2028 (THOUSAND)
TABLE 05. ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY COUNTRY, 2014-2017 ($MILLION)
TABLE 06. ASIA-PACIFIC IVF SERVICES MARKET REVENUE, BY COUNTRY, 2017-2028 ($MILLION)
TABLE 07. ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY COUNTRY, 2014-2017 (THOUSAND)
TABLE 08. ASIA-PACIFIC IVF SERVICES MARKET VOLUME, BY COUNTRY, 2017-2028 (THOUSAND)
TABLE 09. LIST OF A FEW FERTILITY CENTERS IN INDIA
TABLE 10. INDIA IVF SERVICES MARKET REVENUE, BY END USER, 2014-2016 ($MILLION)
TABLE 11. INDIA IVF SERVICES MARKET REVENUE, BY END USER, 2017-2028 ($MILLION)
TABLE 12. INDIA IVF SERVICES MARKET VOLUME, BY END USER, 2014-2016 (THOUSAND)
TABLE 13. INDIA IVF SERVICES MARKET VOLUME, BY END USER, 2017-2028 (THOUSAND)
TABLE 14. INDIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2014-2016 ($MILLION)
TABLE 15. INDIA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2028 ($MILLION)
TABLE 16. INDIA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2014-2016 (THOUSAND)
TA

 
 

The Asia-Pacific region has witnessed changes in the living standards of people and modernization in society which has led to reduction in birth rates. The fertility rates in some of the Asia-Pacific countries, namely Japan, North and South Korea, China, Vietnam, Singapore, and Thailand, are below the threshold replacement fertility level. According to the East West Center Study, Asia’s prosperous economies namely, Japan, South Korea, Singapore, and Taiwan, have the lowest birth rate. Taiwan had the lowest birth per women, which was 8.55 birth per 1000 women, as compared to that of other countries such as South Korea (8.26), Japan (8.07) and Singapore (8.1) in 2014. This was due to couples postponing parenthood and couples preferring few children or rather no children. Thus, the countries in the Asia-Pacific region with lower levels of fertility witness an increase in demand for assisted reproductive technology/treatment (ART) procedures such as  IVF, ICSI, and donor egg, among others.

The Asia-Pacific ART industry is likely to witness significant growth, owing to the low cost of treatment in the region as compared to that of the western countries. Moreover, the success ratio of ART, especially IVF, has increased owing to technological advancements in this region. These factors have fostered the growth of medical tourism industry in this region. Emerging fertility tourism destinations such as India, Thailand, Japan, Malaysia, Singapore, and Australia are chiefly responsible for the growth of Asia-Pacific region, mainly due to the availability of skilled workforce and rise in healthcare awareness in these nations.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Asia-Pacific IVF Services Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers